UOMi005-A

Registration Summary:

A P E C

ALKCS-hiPSC-PT4

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	UOMi005-A
Cite as:	UOMi005-A (RRID:CVCL_A7IM)
Alternative name(s)	ALKCS-hiPSC-PT4
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	19th March 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	University of Manitoba (UOM)
External iPSC Databases
BioSamples	SAMEA8268537
Cellosaurus	CVCL_A7IM
Wikidata	Q107117350
General iPSC Information
Publications	Lester Sequiera G et al. Generation and Evaluation of Isogenic iPSC as a Source of Cell Replacement Therapies in Patients with Kearns Sayre Syndrome. Cells. 2021 Mar 5;10(3). Srivastava A et al. Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome. Stem cell research. 2021 May;53:102355. Srivastava A et al. Generation of human induced pluripotent stem cell (hiPSC) line UOMi005-A from PBMCs of a patient with Kearns-Sayre syndrome. Stem cell research. 2021 May;53:102283. Rafieerad A et al. Development of Fluorine-Free Tantalum Carbide MXene Hybrid Structure as a Biocompatible Material for Supercapacitor Electrodes. Advanced functional materials. 2021 Jul 23;31(30):2100015. Srivastava A et al. Establishment of a new human iPSC cell line (UOMi007-A) from a patient with Hypophosphatasia. Stem cell research. 2022 Aug;63:102839. Adelipour M et al. The role of autophagy in the metabolism and differentiation of stem cells. Biochimica et biophysica acta. Molecular basis of disease. 2022 Aug 1;1868(8):166412. Srivastava A et al. Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A). Stem cell research. 2022 Oct;64:102921. Srivastava A et al. Generation of new human iPSC cell line (UOMi008-A) from a Hypophosphatasia patient. Stem cell research. 2022 Oct;64:102891. Chen Chao et al. Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations. Journal of Biomedical Science. 2023-09-22. Yazdani Mazyar. Cellular and Molecular Responses to Mitochondrial DNA Deletions in Kearns-Sayre Syndrome: Some Underlying Mechanisms. Molecular Neurobiology. 2024-08-00. Srivastava A et al. Reprogramming of peripheral blood mononuclear cells from a patient with hypophosphatasia to generate iPSC line (UOMi011-A). Stem cell research. 2025 Sep;87:103774. Srivastava A et al. Generation of a new human iPSC cell line (UOMi010-A) from a patient with hypophosphatasia. Stem cell research. 2025 Sep;87:103775. Alagarsamy Keshav Narayan et al. TCA cycle intermediates as an adjunct strategy for human iPSC-derived cardiomyocyte maturation. BBA Advances. 2026-00-00. Sharma Gautam et al. iPSC generation from PBMCs of a MELAS patient for mitochondrial dysfunction studies. Stem Cell Research. 2026-08-00.
* Is the cell line readily obtainable for third parties?	No

iPSC Derivation

General